HealthAstraZeneca’s Sone-Ve Enters Expedited FDA Review for Advanced Gastric CancersBy Naomi CalderNov 19, 2026, 2:01 PM UTC
HealthAstraZeneca Drug Doubles Survival in Later-Line CLDN18.2 Cancer TrialBy Naomi CalderOct 26, 2026, 12:32 PM UTC